mTORC1 Overactivation Leads to Abnormalities in Skeletal Development

Area of Science:

• Cellular Biology
• Developmental Biology
• Genetics

Background:

• The mechanistic/mammalian target of rapamycin complex-1 (mTORC1) pathway is crucial for cellular processes and is tightly regulated by Tuberous Sclerosis Complex 1 (Tsc1) and Tsc2.
• Previous studies indicate mTORC1's essential role in skeletogenesis, with its inactivation in mesenchymal cells and chondrocytes causing skeletal abnormalities.

Purpose of the Study:

• To investigate the specific role of mTORC1 hyperactivation in embryonic skeletal development.
• To determine the cell-type specificity of Tsc complex-mediated mTORC1 signaling in skeletogenesis.

Main Methods:

• Utilized mouse genetic models with cell-type specific deletion of Tsc1.
• Employed Prx1-Cre, Col2a1-Cre, and Osx-Cre driver lines to inactivate Tsc1 in distinct embryonic cell populations.
• Analyzed skeletal abnormalities in appendicular and axial skeletons.

Main Results:

• Inactivation of Tsc1 in undifferentiated mesenchymal cells (Prx1-Cre) resulted in appendicular skeletal defects due to mTORC1 hyperactivation.
• Tsc1 deletion in chondrocytes (Col2a1-Cre) or osteoprogenitors (Osx-Cre) did not lead to observable skeletal abnormalities.
• These findings pinpoint undifferentiated mesenchymal cells as critical mediators of mTORC1's influence on skeletal development.

Conclusions:

• Tsc complex-mediated mTORC1 signaling in undifferentiated embryonic mesenchymal cells is essential for normal skeletal development.
• mTORC1's role in skeletogenesis is cell-type specific, with mesenchymal cells being a key regulatory population.
• Targeting mTORC1 in specific embryonic cell types may offer therapeutic avenues for skeletal disorders.